Ịdọ aka ná ntị ọhụrụ na mgbochi ịda mbà n'obi

Ndinaya

• Nyochaa maka

Ọ bụrụ na ị na-ewere otu n'ime ọgwụ ndị na-egbochikarị ịda mbà n'obi, dọkịta gị nwere ike malite inyocha gị nke ọma maka ihe ịrịba ama na ịda mbà n'obi gị na-akawanye njọ, ọkachasị mgbe ịmalite usoro ọgwụgwọ ma ọ bụ gbanwee usoro ọgwụgwọ gị. Ụlọ ọrụ nri na ọgwụ ọjọọ nke United States (FDA) nyere ndụmọdụ na nso nso a maka mmetụta a, dịka ụfọdụ nchọpụta na akụkọ na-egosi na ọgwụ ndị ahụ nwere ike ịbawanye echiche igbu onwe ma ọ bụ omume.Ndị iri ahọpụtara serotonin reuptake inhibitors (SSRIs) na ụmụ nwanne nne ha bụ ịdọ aka na ntị ọhụrụ bụ Celexa (citalopram), Effexor (venlafaxine), Lexapro (escitalopram), Luvox (fluvoxamine), Paxil (paroxetine), Prozac (fluoxetine). ) Remeron (mirtazapine), Serzone (nefazodone), Wellbutrin (bupropion) na Zoloft (sertraline). Ihe ịrịba ama ịdọ aka ná ntị na gị na dọkịta gị kwesịrị ịma gụnyere mmụba nke mwakpo ụjọ, mkpasu iwe, iro, nchekasị na ehighi ura, n'etiti ndị ọzọ.

N'agbanyeghị ndụmọdụ ọhụrụ ahụ, akwụsịla ịṅụ ọgwụ mgbochi ịda mbà n'obi gị. "Ịkwụsị ị medicationụ ọgwụ na mberede nwere ike ịka njọ nke onye ọrịa," ka Marcia Goin, MD, onyeisi oche nke American Psychiatric Association na -ekwu. FDA na-enye ozi nchekwa emelitere na www.fda.gov/cder/drug/antidepressants/.

Nyochaa maka